---
title: "Landfar Bio-medicine revised its 2024 performance forecast, expecting a net loss of 19 million to 21 million yuan"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/236766483.md"
description: "Landfar Bio-medicine released a revised performance forecast for 2024, expecting a net loss of 19 million to 21 million yuan. The company originally expected a net profit of 12.5 million to 15.5 million yuan"
datetime: "2025-04-21T10:29:12.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/236766483.md)
  - [en](https://longbridge.com/en/news/236766483.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/236766483.md)
generator: "portal-rs"
---

# Landfar Bio-medicine revised its 2024 performance forecast, expecting a net loss of 19 million to 21 million yuan

Landfar Bio-medicine released a revised performance forecast for the 2024 fiscal year, expecting a net loss of 19 million to 21 million yuan. The company originally anticipated a net profit of 12.5 million to 15.5 million yuan

### Related Stocks

- [000504.CN](https://longbridge.com/en/quote/000504.CN.md)

## Related News & Research

- [SP Group corrects disclosure, names Schur Finance as buyer of 31,500 shares at DKK 485](https://longbridge.com/en/news/296803384.md)
- [12:35 ETUT Health San Antonio names NIH expert inaugural director of stem cell transplant and cellular therapy program](https://longbridge.com/en/news/296812910.md)
- [Bridge33 Capital acquires Lloyd Crossing retail center in Evansville, Indiana](https://longbridge.com/en/news/296833978.md)
- [Dino Polska S.A. (WSE:DNP) Second-Quarter Results: Here's What Analysts Are Forecasting For This Year](https://longbridge.com/en/news/296763667.md)
- [Oura exploring how its ring could detect brain hemorrhages after Bill Ackman suggests it could have helped his daughter](https://longbridge.com/en/news/296658401.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**